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Rats 4 weeks or older receiving  a single injection of sheep erythrocytes had 
large numbers  of plaque-forming cells in  their spleens  and high  titers  of 19S 
antibody.  Repeated injections  of the antigen  given at  3-  or 4-day intervals 
resulted in a marked decrease in numbers of plaque-forming cells in the spleens, 
although  titers  of 19S and  7S antibody remained  elevated.  The numbers of 
plaque-forming cells and antibody titers remained approximately constant as 
injections of antigen were continued. This stabilization of numbers of plaque- 
forming cells was associated with the short interval between antigen injections, 
since recovery of the response occurred when the interval between antigen in- 
jections was lengthened. Thus, the relatively constant exposure of the animals 
to an antigen provided a mechanism for controlling or limiting the response of 
antibody-forming cells to that antigen (1). 
Previous studies suggested another mechanism for controlling or limiting the 
antibody response to an antigen (2). Specific antibody absorbed onto or incor- 
porated into "potential antibody-forming cells" from normal animals prevented 
these cells from responding to the antigen. Antibody did not have this effect on 
"antibody-forming cells" from animals previously immunized with that antigen. 
Thus, the formation of specific antibody provided a homeostatic or feed back 
mechanism for limiting antibody production to that portion of the antibody- 
forming system previously stimulated by the antigen. 
The data to be  reported  support the  concept that  these two mechanisms, 
one the result of relatively constant antigenic stimulation,  and the other the 
result of formation of small amounts of antibody, are responsible for the induc- 
tion and maintenance of tolerance to sheep erythrocytes produced in rats. 
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Materials and Methods 
The rats and antigen injections were previously described in detail (1). The antigen was 
0.2  ml of  20 per cent  suspension of washed whole erythrocytes injected intraperitoneally. 
Rats receiving antigen injections beginning at the day of birth are referred to as "tolerant" 
animals for convenience. Tolerant rats were always injected on the day of birth and twice 
per week thereafter at regularly alternating 3- and 4-day intervals. The plaque-forming cell 
and antibody response of tolerant rats was compared with 2 control groups of the same age 
and sex:  1 group received a  single injection of antigen at the time when the tolerant rats 
received the last injection of antigen; the 2nd group was non-immunized. 
t~laque-Forming Cells.--The modified technique of Jerne and Nordin for demonstrating 
plaque-forming cells in spleens has been described (1,  2). The preparation and counting of 
plates for animals receiving a single antigen injection were as previously described (1). Since 
spleens of  non-immunized and tolerant rats contained relatively few  plaque-forming cells, 
plates were  inoculated with  larger numbers of spleen cells and additional precautions were 
taken in counting plates prepared from these animals.  Spleens of all tolerant and non-im- 
munized animals were prepared to give a final volume of 2.5 ml in the tissue culture medium. 
Two-tenths ml of the spleen cell suspension (about 4  X  107 nucleated spleen cells) were in- 
oculated  in  each  plate;  5 plates were prepared for each tolerant and each non-immunized 
animal After 1 hour incubation and before the addition of complement, all plates were exam- 
ined using a  magnification of 10 to 25. Any defect in the spleen cell-sheep erythrocyte layer 
which could be mistaken for a  plaque was marked by ink on the underside of the plate and 
was not counted subsequently.  Complement was added  to 3  plates from each animal; the 
same volume of the same complement preparation, inactivated at 56°C  for 30 minutes, was 
added  to  the remaining 2 plates from each animal. The plates were  incubated for  1 hour 
with complement, washed with saline, and counted immediately. Very few plaques developed 
on plates incubated with inactivated complement (a total of 9  "plaques" was found for 3 
non-immunized and 4  tolerant rats; no plaques were present in the plates from other non- 
immunized and  tolerant rats incubated with inactivated complement).  No  correction was 
made for the plaques counted on the plates incubated with inactivated complement. The 
plaques on plates incubated with active complement were  circled by a  sharp needle; each 
plaque was inspected with a conventional microscope at a magnification of 40 and 100  when 
plaques were not close to the edge of the plate. Occasional plaques contained aggregates  of 
tissue debris or possibly extraneous material, and were not counted.  1 
The number of nucleated ceils recovered from spleens was remarkably constant. Within 
experiments, differences in recovery never varied more than 10 per cent between groups of 
tolerant and non-immunized rats, and rats which received a single injection of antigen. Differ- 
ences in recovery of cells from these 3 groups were not consistent. The data are expressed as 
numbers of plaque-forming cells per total spleen rather than as per number of recovered spleen 
cells,  because relatively few plaque-forming cells were present in spleens of tolerant rats. 
Antibody Titers.--The  titration of  sera for hemagglutinins has been described  in detail 
(1). Titrations were for total antibody and for antibody present after treatment of sera with 
2-mercaptoethanol (2-ME),  designated for convenience as 7S antibody. The titrations used 
the double dilution  technique with an initial serum  dilution of  1 : 10. Titers were recorded 
1 Various bacterial contaminants may produce "plaques" which are made more apparent 
by active complement. These plaques have been observed to appear 3 to 6 hours after incuba- 
tion with complement; i.e. 5 to 8 hours after spleen ceils are harvested and plated.  This pos- 
sible source of experimental error is decreased or eliminated by the short incubation period of 
I hour without complement and I hour with complement, rinsing the plates and counting them 
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as the  number of the last  tube showing 1 +  hemagglutination; thus, the titer  expressed 
the  serum dilution of 10 X 2  n where n is the tube number. Mean titers for groups of rats 
4- the standard error of the mean are reported for Table II. A titer of 0 was arbitrarily as- 
signed to sera showing less than the end point reaction at a serum dilution of 1:10. 
Plate Hemolysin Tit~rs.--Agar plates were prepared as for demonstrating plaque-forming 
cells (2), but only sheep erythrocytes were added to agar in the thin overlayer. Small droplets 
of heat-inactivated serum and of serial twofold dilutions of the serum were spotted on the 
plate. The plates were incubated briefly, rinsed with saline and flooded with fresh rat comple- 
ment, and incubated again. Serum-containing antibody produced clear plaques of complete 
hemolysis 2 to 3 mm in diameter. Higher dilutions of antibody produced distinct plaques of 
partial hemolysis. 
EXPERIMENTAL OBSERVATIONS 
The Plaque-Forming Cell and Antibody Response of Tolerant Rats.--The maxi- 
mum interval between injections of antigen was 4  days. It was,  therefore, of 
interest to measure the plaque-forming cell and antibody response at this inter- 
val in rats which had received various numbers of antigen injections. Further- 
more, the response 4  days after the last antigen injection could be compared 
with the response of the adult rats immunized in the same manner (1). 
New-born rats from 5 litters delivered on the same day were injected with 
antigen; injections were repeated twice a  week at regularly alternating 3- and 
4-day intervals. The response of the tolerant rats was compared with:  (a) the 
response of rats of similar or equal age which received a single antigen injection 
when the tolerant rats received their last antigen injection; and (b) rats of the 
same age which received no immunization. Groups of 4 to 6 tolerant rats, along 
with groups of control rats, were sacrificed 4 days after they had received a total 
of 5 to 42 antigen injections. The responses of the individual rats are recorded in 
Table I. 
All 6 rats receiving 5 antigen injections (injected at 1, 4, 7, 11, and 14 days of 
age and sacrificed at age 18 days) had 3000 to  22,000  plaque-forming cells  in 
their spleens and antibody titers of 2 to 4. Their response was equivalent to the 
response of control rats which received a single antigen injection. 
It was previously shown that rats receiving a single antigen injection on the 
day of birth or at age 7 days had no measurable plaque-forming cell and anti- 
body response (1). Apparently, the first 3 or 4 antigen injections produced no 
appreciable response and the 5th antigen injection produced a response equiva- 
lent to that of a  single antigen injection given at this age. Clearly, these rats 
which received only 5 antigen injections were not immunologically unrespon- 
sive or tolerant. 
The responses for 16 rats, sacrificed 4 days after they had received 15, 17, 22, 
or 30 antigen injections, contrasted sharply with the responses of the rats which 
received only 5 antigen injections.  The 16 rats had from 143 to 1800 (mean 504) 
plaque-forming cells in their spleens, about 8 times as many plaque-forming cells 
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TABLE  I 
Plaque-Forming Cell and Antibody  Response to Multiple Antigen  Injections  Begun 
at Birth 
TolersntS  Controls 
No. of Injections  Non-injected§  Single injections 
15 
17 
22 
30 
42 
5* 
Plaque-forming 
cells per spleen 
22,000 
21,000 
7,000 
6,000 
6,000 
3,000 
268 
208 
158 
143 
1,800 
750 
483 
275 
740 
583 
493 
283 
788 
569 
288 
238 
563 
438 
325 
250 
Antibody titer 
Plaque-forming 
cells per spleen 
144 
113 
113 
68 
43 
38 
8 
100 
50 
42 
42 
125 
83 
58 
40 
131 
106 
75 
63 
50 
100 
88 
75 
63 
63 
38 
Plaque-forming 
cells per spleen 
29,000 
18,000 
10,000 
8,000 
5,000 
946,000 
826,000 
358,000 
386,000 
436,000 
275,000 
87,000 
40,000 
28,000 
27,000 
466,000 
414,000 
228,000 
125,000 
48,000 
610,000 
190,000 
183,000 
97,000 
97,000 
75,000 
Antibody titer 
* The tolerant and non-injected controls were 18 days old at sacrifice; the single injection 
controls were 21 days old at sacrifice. The tolerant rats receiving more than 5 antigen injec- 
tions and their controls were the same age at sacrifice. 
:~ All tolerant rats were sacrificed 4 days after the last antigen injection; all control rats 
were sacrificed 4 days after the single antigen injection. Results for animals within groups 
have been arbitrarily arranged according to numbers of plaque-forming cells in spleens. 
§ Antibody titers were 0 for all non-injected controls. DONALD A. ROWLEY  AND  FRANK  W. ]~ITCH  687 
10 of the tolerant rats, and 2 to 3 for 6 of the tolerant rats. The numbers of 
plaque-forming cells in spleens of the tolerant rats did not correlate with hemag- 
glutinin titers. Four tolerant rats, age 146 days, sacrificed 4 days after the 42nd 
antigen injection, showed no increase in numbers of plaque-forming ceils; but 
all 4 animals had hemagglutinin titers ranging from 1 to 8. The hemagglutinin 
titers were 0 for all the non-immunized control rats. The control rats, which re- 
ceived a single injection  of antigen,  had large numbers of plaque-forming  ceils 
in their spleens and antibody titers ranging from 4 to 8. 
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FIG. 1.  Comparison of the decline of the plaque-forming cell response produced by multi- 
ple antigen injections in adult and tolerant rats• Antigen injections were given twice a week. 
The response was measured 4  days after the last antigen injection• The data for the adult 
rats were presented in detail previously (1)• 
The animals receiving 5 antigen injections had responses equivalent to rats 
of similar age which had received only a single antigen injection. The animals 
receiving 15 to 42 antigen injections had about ~0 the number of plaque-form- 
ing cells in their spleens as the animals receiving 5 antigen injections. The num- 
bers of plaque-forming cells produced by more than 5 antigen injections stabi- 
lized as antigen injections were continued. Adult animals receiving 3 or more 
injections of the same dose of antigen as the tolerant rats in the present experi- 
ment had decreased numbers of plaque-forming cells in their spleens; the num- 
bers of plaque-forming cells  also stabilized with continued antigen injections 
(1). These findings for adult and tolerant rats are illustrated in Fig. 1.  2 
2 In other experiments, tolerant rats were sacrificed 3 or 4 days after they had received 7, 
9, or 13 antigen injections. The numbers of plaque-forming cells in the spleens of these animals 
were comparable to the numbers of plaque-forming cells recorded for the tolerant rats receiving 
15 to 42  antigen injections in Table I. Thus,  the sharp drop in numbers of plaque-forming 
cells plotted for the tolerant animals in Fig. 1 is probably justified. 688  TOLERANCE  IN RATS  TO  SHEEP  ERYTHROCYTES.  II 
Repeated antigen injections produced a greater decrease in the plaque-form- 
ing cell response in the tolerant rats than in rats immunized as adults. However, 
this difference was not great, and the time sequence for the decrease was similar 
for the adult and the tolerant rats. The findings suggested that the mechanism 
producing the decline in numbers of plaque-forming  ceils was similar in both 
groups of animals. 
Tolerant rats which had received 13 or 22 antigen injections were sacrificed 
15, 18, or 32 days after the final antigen injection. The numbers of plaque-form- 
ing cells in the spleens of these animals were always lower than in comparable 
tolerant rats sacrificed 4 days after the last antigen injection. The antibody ti- 
ters were 0 for these rats. Thus, no late rise in numbers of plaque-forming cells 
TABLE  H 
Recovery of the Plo~e-Forming Cell and Antibody Response in Tolerant Rats 
Plaque-forming ceils per 
spleen~ .................. 
Antibody titer~: ........... 
Days between the last 2 antigen injections* 
3 
(4 rats) 
470  :& 128 
1.0  &  0.58 
14 
(4 rats) 
1,790  -4-  480 
0 
28 
(5 rats) 
4,410  :t: 2,080 
4.4  fl: 0.24 
Controls 
Non-injected 
(5 rats) 
85  4-  15 
0 
1 antigen injection 
(5 rats) 
256,000  :t: 113,000 
6.4  :~ 0.51 
* The rats received a total of 23, 27, or 30 antigen injections. 
Animals sacrificed 4 days after the last antigen injection. Results are expressed as the mean :t: the standard 
error of the mean, 
or in antibody titers occurred with cessation of antigenic stimulation, a  find- 
ing identical to that observed in rats similarly immunized as adults (1). 
The following experiment was designed to determine whether an increased 
interval between the last 2 antigen injections of a series resulted in recovery of 
the plaque-forming cell and antibody response in tolerant rats. 
Recovery of the Plaque-Forming Cell and Antibody Response in Tolerant Rats.- 
The spleens of tolerant rats which had received 15 antigen injections contained 
low  numbers  of  plaque-forming  cells;  the  numbers  of  plaque-forming  cells 
stabilized at this low level as antigen injections were continued. Similar stabili- 
zation of plaque-forming cells, but at a higher level, occurred when rats received 
repeated antigen injections as  adults.  A  progressive recovery of the plaque- 
forming cell response occurred in adults rats when the interval between the last 
2 antigen injections was increased. It was of interest to determine whether simi- 
lar recovery occurred in tolerant rats. 
The tolerant rats  were litter mates  of the  animals  tested in  the previous 
experiment,  Table  I.  Antigen  injections  were  discontinued  for  1  group  of 
tolerant rats after they had received 22 antigen injections, and for a 2nd group 
of tolerant rats after they had received 26 antigen injections. Antigen injections DONALD  A.  ROWLEY  AND  FRANK  W.  FITCH  689 
were continued for a 3rd group of tolerant rats. All 3 groups were injected with 
antigen when the 3rd group received the 30th antigen injection. Thus, the inter- 
val between the 22nd and 23rd antigen injections was 4 weeks for 1 group, and 
the interval between the 26th and 27th antigen injections was 2 weeks for the 
2nd group. The rats were sacrificed 4 days after the final antigen injection along 
with non-immunized animals and animals which had received a single antigen 
injection. The responses of these animals are presented in Table II.  (The in- 
dividual responses for the tolerant rats receiving 30 antigen injections and for 
the controls were presented in Table I.) 
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FIG. 2. Comparison of the recovery of the plaque-forming cell response produced by in- 
creasing the interval between the last 2 antigen injections in adult and tolerant rats. The 
response was measured  4 days after the last antigen injection. The data for the adult rats were 
presented in detail previously (1). 
When the interval between the last 2 antigen injections was 2 weeks, the rats 
had about 4 times as many plaque-forming cells in their spleens as the tolerant 
rats receiving continuous antigen injections; the antibody titers were 0 for these 
rats. When the interval between the last 2 antigen injections was 4 weeks, the 
rats  had about 9  times as many plaque-forming cells in their spleens as  the 
tolerant  rats  receiving  continuous  antigen  injections;  all  of  these  rats  had 
moderately high antibody titers of 4 to 5 (titers for 7S antibody ranged from 1 
to 3). 
The recovery of the plaque-forming cell response of the tolerant rats is com- 
pared with the recovery in rats immunized as adults (1) in Fig. 2. An interval 
of 4 weeks between antigen injections resulted in a slightly greater recovery in 
the tolerant rats than in the rats/mmunized as adults. The time sequence for 
the recovery of the response was similar for the  2  groups.  The findings  sug- 690  TOLERANCE  IN  RATS  TO  SHEEP  ERYTHROCYTES.  II 
gested that the mechanism producing recovery of the plaque-forming cell and 
antibody response was similar in both groups of animals. 
The Antibody Response of Tolerant Rats.--The presence of circulating anti- 
body in some tolerant rats provided evidence that the increased numbers of 
plaque-forming cells in tolerant rats was indicative of increased antibody forma- 
tion.  However, some rats had no detectable antibody by the hemagglutinin 
test. Plate hemolysin titrations, providing a more sensitive method for demon- 
strating circulating antibody in whole serum or low dilutions of serum, were 
done on sera from the tolerant and non-immunized rats reported in Table I. 
Sera from tolerant rats having hemaglutinin titers of 1 or higher all produced 
"plaques" of complete hemolysis at a serum dilution of 1:10 and were not ti- 
trated at higher serum dilutions. Sera from 9 of 10 tolerant rats having negative 
hemagglutinin titers (serum dilution of 1:10) produced plaques of complete to 
partial hemolysis at dilutions of 1:2 to 1:32. A single undiluted serum from a 
tolerant rat which received 17 antigen injections and had 483 plaque-forming 
cells in its spleen produced no hemolysis. Undiluted sera from several non-im- 
munized rats produced a trace of hemolysis; none of the sera from non-immu- 
nized rats diluted 1: 2 produced hemolysis. 
The plate hemolysin technique was used to test sera for hemolytic antibody 
after treatment with 2-ME, but the lowest serum dilution which could be tested 
was 1: 5. The sera from tolerant rats having hemagglutinin titers of 1 or higher 
contained 7S antibody in serum dilutions of 1: 5; two sera from tolerant rats 
having negative hemagglutinin titers had 7S antibody in serum dilutions of 1:5. 
The findings were sufficient to indicate that some tolerant rats produced small 
amounts of a mixture of 19S and 7S antibody. Thus, the tolerant rats had more 
plaque-forming cells in their spleens than non-immunized rats, and all but 1 of 
the tolerant rats had demonstrable circulating antibody. The amount of circu- 
lating antibody did not correlate well with numbers of plaque-forming cells in 
the spleens of individual tolerant rats, but this absence of correlation was also 
observed for rats which received multiple antigen injections as adults (1). 
The Inhibition of the Plaque-Forming Cell Response by Antibody.--Small  quan- 
tities of anti-sheep erythrocyte antibody given passively or produced by active 
immunization inhibited the antibody response of potential antibody-forming 
cells (2, 3). The antibody produced by relatively few antibody-forming cells in 
tolerant  rats  would presumably prevent  potential antibody-forming cells  of 
tolerant rats from responding to the antigen. In the following experiment, pas- 
sively-given  antibody produced  profound  inhibition  of  the  plaque-forming 
cell response of growing rats. 
Each of six 16-day-old rats was injected intravenously  with 0.5 ml of rat anti- 
sheep erythrocyte serum, a dose calculated to give circulating antibody titers 
of 1 to 2 at 24 hours after passive immunization. The following  day these rats and 
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with 0.2 ml of 20 per cent sheep erythrocytes. All were sacrificed 4 days later. 
The spleens of the passively immunized rats contained 25 to 200 plaque-form- 
ing cells per spleen;  the spleens of the control rats contained 4000 to 18,000 
plaque-forming  cells per spleen. 
Presumably sustained antibody production at low levels by the tolerant rats 
would inhibit potential antibody-forming cells from responding to the antigen. 
DISCUSSION 
Objections can be raised to use of the word "tolerance" to describe the type 
of immunological unresponsiveness we have studied,  since this word has been 
used by many to describe the absence of homograft rejection  and the latter is 
generally considered to be mediated by "hypersensitive cells" and not by circu- 
lating  antibody. The  suppression  of  antibody formation is  not  necessarily 
equivalent to suppression  of hypersensitivity. Moreover,  for some biologists, 
tolerance  by definition  means the complete  absence of an immunological  re- 
sponse. The tolerant animals in the present experiments  had a demonstrable 
immune response to the antigen used to produce tolerance. For the present, we 
do not believe that a rigid definition of the word is desirable, since the same bio- 
logical mechanisms may be involved in the induction and maintenance of im- 
munological unresponsiveness produced by various experimental procedures. 
Various procedures besides neonatal injections  of antigen suppress both the 
circulating  antibody response and hypersensitivity reactions. Both delayed hy- 
persensitivity and circulating antibody can be suppressed in mature guinea pigs 
by feeding of a hapten or by injecting very small amounts of a hapten or a solu- 
ble protein into mesenteric veins (4-5).  Passive immunization of adult animals 
may produce immunological enhancement of tumor or skin grafts (7, 8). Thy- 
mectomy, X-irradiation, chronic drainage of lymph from the thoracic duct, and 
other procedures  producing  involution, depletion,  or destruction of lymphoid 
tissue may suppress both kinds of immunological responses (9-12). 
Clearly, animals are tolerant if there is complete absence of an immunological 
response to an antigen, but we do not know of experimental  systems where it 
has been shown conclusively that there was complete absence of an immuno- 
logical response to the antigen in the tolerant animals. For example, homograft 
survival alone may not be valid evidence for the absence of an immune response 
since various procedures which do not abolish the immune response may result 
in prolonged homograft survival. Obviously, the sensitivity of the assay system 
will determine whether or not an immune response can be detected. In the pres- 
ent experiments, it required a method capable of detecting a few hundred anti- 
body-forming cells in an entire spleen (using an antibody titration system suffi- 
ciently sensitive to detect antibody released from single cells) to demonstrate an 
immunologic response in some tolerant animals. Therefore, it seems reasonable 
to  expect  that  extremely sensitive  methods  will  be  required  to  determine 692  TOLERANCE  IN  RATS  TO  SHEEP  ERYTHROCYTES.  II 
whether or not an active immune process is  essential for maintenance of tol- 
erance to other antigens and to homografts. 
The reasons for separating cells capable of responding to antigen into two 
categories,  "potential antibody-forming cells" and  "antibody-forming cells," 
were discussed in detail (2). The designation of potential  antibody-forming  cells 
is applied to cells from normal animals which at a  given time are capable of 
responding to a specific antigen. However, these cells are unresponsive to anti- 
gen in the presence  of specific  antibody to the  antigen.  The designation  of 
antibody-forming  cells is applied to cells which have been modified by previous 
encounter with the antigen. These ceils respond to the antigen in the presence 
of specific antibody to the antigen. These designations are used primarily for 
the sake of convenience in discussion; the terms may describe two completely 
different classes  of cells or may merely indicate the extremes of a  spectrum of 
functional states of a  single class of cells.  On the other hand, the category of 
potential antibody-forming cells may include two different cell  types  such as 
macrophages and lymphocytes, while the category  of antibody-forming cells 
may constitute a class of cells which can respond to antigen directly. 
Two mechanisms are proposed to explain the induction and maintenance of 
tolerance, one which controls or limits the response of antibody-forming cells, 
and the other which controls or limits the induction or transformation of poten- 
tial antibody-forming cells to antibody-forming cells.  The following evidence 
supports the operation of the first mechanism. Rats receiving repeated injec- 
tions had  stabilized numbers  of plaque-forming cells in  their spleens.  When 
antigen injections were begun in adults, the numbers of antibody-forming cells 
stabilized at high levels, and these animals had high antibody titers. When in- 
jections were begun at birth, the numbers stabilized at low levels, and the ani- 
mals had very low titers of antibody. Presumably, the mechanism producing 
stabilization of numbers  of plaque-forming cells and antibody titers was  the 
same whether antigen injections were begun in adults or at birth. An appreci- 
able increase in plaque-forming cells and antibody response occurred when the 
interval between the last two of a series of antigen injections was increased. This 
was true although the antibody titer at the time of the last injection remained 
elevated. The rate of recovery was the same for tolerant rats and rats immunized 
as adults, suggesting that a similar process operated in both. It seems likely that 
repeated closely spaced antigen injections interfere with either division or mat- 
uration of antibody-forming cells. A stabilization of numbers of plaque-forming 
cells and antibody titer results; as  the  interval between antigen injections is 
increased,  additional  antibody-forming  cells  mature  or  are  formed  by  cell 
division (1). 
The mechanism producing stabilization of numbers of plaque-forming cells 
and antibody titers would not explain why stabilization occurred at low levels 
for tolerant rats and at high levels for rats injected as adults. A second mecha- DONALD  A. ROW'LEY AND  ~FRANK W. ~ITCH  693 
nism controlling or limiting  the induction or transformation of potential anti- 
body-forming cells to antibody-forming cells would account for this finding. 
The plaque-forming cell response to the antigen was not detectable during 
the 1st week but rose to adult levels by the 5th or 6th week of extrauterine life. 
Hence, a very rapid growth of potential antibody-forming cells occurred during 
this time. The tolerant rats had a plaque-forming cell and antibody response 
during the 3rd week of life equivalent to that of rats of similar  age which had 
received a single antigen injection; but quantitatively, this response was much 
lower than in adult animals receiving similar antigen injections.  Continued an- 
tigen injections in the growing animals produced a decline and stabilization of 
this relatively small population of antibody-forming cells. Passively adminis- 
tered antibody profoundly inhibited the plaque-forming cell and antibody re- 
sponse of growing  rats. It seems likely,  therefore, that antibody actively pro- 
duced by this small  population of antibody-forming cells in tolerant rats in- 
hibited the response of the growing  population of potential antibody-forming 
cells, in a manner similar  to that produced by passive administration  of anti- 
body. 
Previous findings also support the concept that the production of antibody in 
small quantities may limit the antibody response.  Unresponsiveness to sheep 
erythrocytes induced in adult rats by a single passive immunization  was sus- 
tained for several months by weekly injections of sheep erythrocytes (3). The 
inhibitory effect of the passive immunization lasted less than 2 weeks. Therefore, 
the suppression was presumably sustained by antibody produced actively by 
relatively few antibody-forming cells. Furthermore, adult rats were made un- 
responsive to a large dose of sheep erythrocytes by initial active immunization 
with small doses of the antigen;  unresponsiveness was sustained by repeated 
antigen  injections (2).  Again,  unresponsiveness presumably resulted from in- 
hibition of potential antibody-forming cells by antibody produced by relatively 
few antibody-forming cells stimulated by the initial small dose of antigen. 
Suppression of the antibody response,  whether in tolerant rats or rats made 
unresponsive by passive or active immunization,  presumably occurs when a 
critical balance exists between the numbers of antibody-forming cells and the 
amount of antibody produced. Sufficient antibody has to be produced to block 
potential antibody-forming cells from responding to subsequent antigenic stim- 
ulation. On the other hand,  the numbers of antibody-forming cells can not be 
so numerous as to produce appreciable circulating antibody to subsequent anti- 
genic stimulation.  Clearly, the concept of tolerance developed in these studies 
demands an active immune response with the production of antibody in small 
quantities for the maintenance  of tolerance. 
SUMMARY 
An active immune response to sheep erythrocytes was demonstrated in rats 
made "tolerant" to sheep erythrocytes by twice-weekly antigen injections be- 694  TOLERANCE  IN  RATS  TO  SHEEP  ERYTHROCYTES.  II 
ginning on the day of birth. Groups of tolerant rats were sacrificed 4 days after 
they had received 5 to 42 antigen injections; spleens were sampled for plaque- 
forming (antibody-releasing) cells and sera were titrated for antibody to sheep 
erythrocytes using a sensitive "plate hemolysin" technique. 
During the 3rd week of life and after the 5th antigen injection, the tolerant 
rats had an immune response equivalent to that of rats of similar age which had 
received a single antigen injection, but spleens contained only about one-tenth 
as many plaque-forming cells as adults animals receiving similar antigen injec- 
tions. Continued antigen injections produced a marked decline and stabilization 
of this relatively small population of antibody-forming cells; however, the num- 
ber of plaque-forming cells in the tolerant rats remained considerably elevated 
above the numbers of plaque-forming cells present in  the  spleens  of non-im- 
munized animals. The sera from all but 1 tolerant rat had demonstrable anti- 
body to sheep erythrocytes in low titer. A progressive recovery of the plaque- 
forming cell responge and rise in antibody titers occurred in adult tolerant rats 
when the interval between the last 2 antigen injections was increased from 3 
days to 14 or 28 days. 
The decline and stabilization of numbers of plaque-forming cells occurring 
with continued injections after the 3rd week of life paralleled a similar decline 
and stabilization in rats receiving similar antigen injections as adults. Also,  the 
recovery of the plaque-forming cell and antibody response of tolerant animals 
paralleled the recovery observed when the interval between injections was in- 
creased in rats  receiving similar antigen injections as adults.  These findings 
suggested that the same mechanism controlled numbers of antibody-forming 
cells in tolerant and normally responsive adult animals. Repeated closely spaced 
antigen injections presumably interfered with either cell division or maturation 
of antibody-forming cells. As the interval between injections was increased, ad- 
ditional antibody-forming cells matured or were formed through cell division. 
Relatively constant antigenic stimulation provided a mechanism for controlling 
or limiting the response of antibody-forming cells. 
The mechanism controlling or limiting the response of antibody-forming cells 
would not account for the stabilization of numbers of antibody-forming cells 
at high levels for normal animals and at low levels for the tolerant animals. 
Passive immunization of growing rats with homologous anti-sheep erythrocyte 
serum markedly inhibited the plaque-forming cell response of growing rats. It 
was proposed that antibody produced by the small population of antibody-form- 
ing cells in the tolerant rats provided a  feedback or homeostatic mechanism 
which inhibited transformation of potential antibody-forming cells to antibody- 
forming cells. Thus, tolerance to  sheep  erythrocytes was induced and main- 
tained by two mechanisms. One mechanism, dependent on relatively constant 
antigenic stimulation, limited or controlled the numbers of antibody-forming 
cells. The other, dependent on the production of small quantities of antibody DONALD A.  ROWLEY AND FRANK W.  I~ITCR"  695 
by a few antibody-forming cells, limited or controlled the transformation of po- 
tential antibody-forming cells to antibody-forming cells. 
It is a pleasure to acknowledge  the skilled and devoted assistance of Mrs. Inger Bye Perry 
in these studies. 
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